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Abstract
Background: X-linked mental retardation (XLMR) is the leading cause of mental retardation in
males. Mutations in the ARX gene in Xp22.1 have been found in numerous families with both
nonsyndromic and syndromic XLMR. The most frequent mutation in this gene is a 24 bp duplication
in exon 2. Based on this fact, a panel of XLMR families linked to Xp22 was tested for this particular
ARX mutation.
Methods: Genomic DNA from XLMR families linked to Xp22.1 was amplified for exon 2 in ARX
using a Cy5 labeled primer pair. The resulting amplicons were sized using the ALFexpress
automated sequencer.
Results: A panel of 11 families with X-linked mental retardation was screened for the ARX 24dup
mutation. Four nonsyndromic XLMR families – MRX29, MRX32, MRX33 and MRX38 – were found
to have this particular gene mutation.
Conclusion: We have identified 4 additional XLMR families with the ARX dup24 mutation from
a panel of 11 XLMR families linked to Xp22.1. This finding makes the ARX dup24 mutation the most
common mutation in nonsyndromic XLMR families linked to Xp22.1. As this mutation can be
readily tested for using an automated sequencer, screening should be considered for any male with
nonsyndromic MR of unknown etiology.
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Background
The causes of mental retardation (MR) are exceptionally
heterogeneous. More than 50 genes found on the human
X chromosome have been reported to cause MR with
another 150 loci being associated with linked syndromes,
nonsyndromic families and unlinked syndromes [1,2].
The aristaless-related homeobox gene, ARX, maps to
Xp22.1-p21.3, encompasses a genomic region of approxi-
mately 12.5 kb and is composed of 5 encoding exons [3].
The most frequent mutation reported in ARX is an in-
frame 24 bp duplication in exon 2, which causes an
expansion of the polyalanine tract at amino acid positions
144–155, from 12 to 20 alanines. This duplication has
been reported in a Norwegian family with West Syndrome
[3,4] as well as four published nonsyndromic XLMR fam-
ilies, MRX36 [5], MRX43, MRX54 and MRX76 [6]. We
have recently identified the same 24 bp duplication in 4
other nonsyndromic XLMR families linked to Xp22.1:
MRX29 [7], MRX32 [8], MRX33 [9], and MRX38 [10].
Methods
Genomic DNA from members of eleven XLMR families
linked to Xp22.1, a West Syndrome family with a 21 bp
insertion [3], two positive controls for the 24 bp duplica-
tion (dup24) [3], and a negative control was amplified by
PCR using locus specific primer pairs designed for exon 2
of ARX. The Cy5 labeled forward primer sequence,
ARXex2P1, was 5'ACG CCT GGG CCT AGG CAC TG 3'
and the reverse primer sequence, ARXex2P1, was 5' CTC
GGT GCC GGT GCC ACC AC 3'. These primers flank both
the (GCG)10+7 and dup24 mutations. The size of the nor-
mal control PCR product is 584 bp, while the (GCG)10+7
mutation gives a 605 bp product and the dup24 mutation
a 608 bp product. The parameters of the reaction con-
sisted of an initial denaturation at 95°C followed by 30
cycles consisting of 95°C for 30 seconds, 62°C for 30 sec-
onds, and 72°C for 30 seconds and completing with a
final extension at 72°C for 5 minutes. PCR amplification
was verified using a 1.5 % agarose gel, run at 120 volts,
and stained with ethidium bromide. PCR products were
then analyzed using the Amersham Biosciences
ALFexpress1.
Results
The analysis revealed an altered pattern in a female carrier
of MRX38 and one affected male from each of three other
families: MRX29, MRX32, MRX33 (Figure 1). The pattern
was identical to that observed for two samples known to
have the dup24 mutation in exon 2 of ARX and clearly dis-
tinct from the 21 bp insertion in exon 2 that is present in
the patient with West Syndrome (Figure 1). DNA sequenc-
ing of the PCR products confirmed the presence of the
dup24 mutation. It is important to note the discrepancy in
the size of the dup24 mutation and the sizing standard in
lanes 1 and 4 (Figure 1). We hypothesize that the slower
migration pattern observed for the dup24 mutation (~645
bp instead of the expected 608 bp) is due to its secondary
(hairpin) structure.
Discussion
We have identified the dup24 mutation in exon 2 of ARX
in four additional nonsyndromic XLMR families (MRX29,
32, 33, and 38) linked to Xp22.1. This same alteration has
been observed in four other published nonsyndromic
families, MRX36 [5], MRX43, MRX56 and MRX76 [6]
linked to Xp22.1. As a result, this single mutation
accounts for 8/11 (73%) of MRX families linked to
Xp22.1 [11]. This 24 bp duplication is not restricted to
nonsyndromic XLMR families. A family with West syn-
drome linked to Xp22.1 had this alteration [4], as well as
2 families with Partington syndrome, also linked to
Xp22.1 [3]. This association of nonsyndromic and syn-
dromic XLMR with the 24 bp duplication has also been
noted by Kato et al [12].
The dup24 also accounts for 2/10 (20%) syndromic
XLMR conditions linked to Xp22.1 [13,14]. This is quite
striking and noteworthy since for most XLMR genes
described thus far, mutations are found in less than 20%
of families linked to any particular region [15]. Overall, it
appears that when all mutations in ARX are considered,
alterations in the gene accounts for 4/58 (7%) syndromic
and 8/24 (25%) nonsyndromic XLMR conditions with
known gene defects. Again, this is uncharacteristic of
other XLMR genes, except for ATRX/XNP (mutations in 6
syndromes) or PQBP1 (mutations 5 syndromes) [14].
This being said, there is a "disconnect" when screening for
ARX mutations is expanded to the general male MR pop-
ulation. Bienvenu et al. [6] were only able to identify two
mutations in a panel of 148 XLMR families and only one
dup24 mutation in 40 sporadic males with MR. Addition-
ally, Gronskov et al. [16] identified only one dup24 muta-
tion out of 682 patients. Other studies experienced a
similar failure to find this mutation in 577 males with
non-fragile X MR (Stepp and Schwartz, unpublished) and
a cohort of 188 male patients [15]. This translates to a pos-
itive screen rate of 2/1501 male patients with MR, signifi-
cantly different from the 6.6% rate observed in proven
XLMR families [15].
At present, there is no clear explanation for this disparity
in the frequency of ARX mutations between families with
XLMR linked to Xp22.1 and sporadic cases of males with
MR. It may simply mean that the assumption that the 25–
30% excess of males with MR is due to genes on the X
chromosomes is incorrect. Therefore, the male excess in
the MR population might have to be accounted for by
other mechanisms including yet to be revealed X-chromo-
some linked factors.BMC Medical Genetics 2005, 6:16 http://www.biomedcentral.com/1471-2350/6/16
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Conclusion
In conclusion, we have shown that 4 additional MRX fam-
ilies (MRX29, 32, 33 and 38), mapped to Xp22.1, have the
dup24 mutation in exon 2 of the ARX gene. This mutation
accounts for about 70% of MRX families linked to Xp22.1.
However, it has been difficult to find this same mutation
in large cohorts of males with mental retardation. None-
theless, as the 24dup mutation in ARX can easily be tested
using an automated DNA sequencer, screening of males
with MR of unknown etiology for this particular mutation
should be given consideration.
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